Proprio, the surgical navigation company ‘creating the most transformative technology in surgery since the X-ray’, has landed $23 million in series A funding Quick read…
Pear Therapeutics and Proprio have strengthened their hands in delivering immersive services to patients and medical professionals. Quick read ➨ Pear has acquired two clinical-stage…